Takahashi N, Hara H, Nagashima K, Hirata K, et al. Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab
(RAM) versus trifluridine/tipiracil for previously treated patients with advanced
gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G). BMC Cancer 2023;23:726.
PMID: 37543568